293 related articles for article (PubMed ID: 19034702)
1. Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway.
Miyakoshi T; Takei M; Kajiya H; Egashira N; Takekoshi S; Teramoto A; Osamura RY
Endocr Pathol; 2008; 19(4):261-73. PubMed ID: 19034702
[TBL] [Abstract][Full Text] [Related]
2. Wnt4 is overexpressed in human pituitary adenomas and is associated with tumor invasion.
Li W; Zhang Y; Zhang M; Huang G; Zhang Q
J Clin Neurosci; 2014 Jan; 21(1):137-41. PubMed ID: 24200887
[TBL] [Abstract][Full Text] [Related]
3. Expression of FOXL2 in human normal pituitaries and pituitary adenomas.
Egashira N; Takekoshi S; Takei M; Teramoto A; Osamura RY
Mod Pathol; 2011 Jun; 24(6):765-73. PubMed ID: 21478824
[TBL] [Abstract][Full Text] [Related]
4. No evidence for WT1 involvement in a beta-catenin-independent activation of the Wnt signaling pathway in pituitary adenomas.
Schittenhelm J; Psaras T; Honegger J; Trautmann K; Meyermann R; Beschorner R
Endocr Pathol; 2009; 20(3):158-62. PubMed ID: 19437143
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of retinoid X receptor isoforms in human pituitaries and pituitary adenomas.
Sanno N; Sugawara A; Teramoto A; Abe Y; Yen PM; Chin WW; Osamura RY
Neuroendocrinology; 1997 Apr; 65(4):299-306. PubMed ID: 9143002
[TBL] [Abstract][Full Text] [Related]
7. Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Immunohistochemical studies using an antibody against synthetic human Pit-1 product.
Sanno N; Teramoto A; Matsuno A; Osamura RY
Arch Pathol Lab Med; 1996 Jan; 120(1):73-7. PubMed ID: 8554449
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling in estrogen-induced lactotroph proliferation.
Giles A; Madec F; Friedrichsen S; Featherstone K; Chambers T; Harper CV; Resch J; Brabant G; Davis JR
J Cell Sci; 2011 Feb; 124(Pt 4):540-7. PubMed ID: 21245194
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of growth-related factors in human pituitary adenomas. Lowered insulin-like growth factor-I and its receptor mRNA in growth hormone-producing adenomas.
Otsuka F; Tamiya T; Yamauchi T; Ogura T; Ohmoto T; Makino H
Regul Pept; 1999 Aug; 83(1):31-8. PubMed ID: 10498342
[TBL] [Abstract][Full Text] [Related]
10. Impact of the Canonical Wnt Pathway Activation on the Pathogenesis and Prognosis of Adamantinomatous Craniopharyngiomas.
Jucá CEB; Colli LM; Martins CS; Campanini ML; Paixão B; Jucá RV; Saggioro FP; de Oliveira RS; Moreira AC; Machado HR; Neder L; Antonini SR; de Castro M
Horm Metab Res; 2018 Jul; 50(7):575-581. PubMed ID: 29625497
[No Abstract] [Full Text] [Related]
11. Expression of Rab3, a Ras-related GTP-binding protein, in human nontumorous pituitaries and pituitary adenomas.
Tahara S; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 1999 Jun; 12(6):627-34. PubMed ID: 10392640
[TBL] [Abstract][Full Text] [Related]
12. Application of catalyzed signal amplification in immunodetection of gonadotropin subunits in clinically nonfunctioning pituitary adenomas.
Sanno N; Teramoto A; Sugiyama M; Itoh Y; Osamura RY
Am J Clin Pathol; 1996 Jul; 106(1):16-21. PubMed ID: 8701926
[TBL] [Abstract][Full Text] [Related]
13. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas.
Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A
Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation.
Jiang F; Parsons CJ; Stefanovic B
J Hepatol; 2006 Sep; 45(3):401-9. PubMed ID: 16780995
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas.
Jameson JL; Klibanski A; Black PM; Zervas NT; Lindell CM; Hsu DW; Ridgway EC; Habener JF
J Clin Invest; 1987 Nov; 80(5):1472-8. PubMed ID: 2824561
[TBL] [Abstract][Full Text] [Related]
16. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA Plasmacytoma Variant Translocation 1 (PVT1) Enhances Proliferation, Migration, and Epithelial-Mesenchymal Transition (EMT) of Pituitary Adenoma Cells by Activating β-Catenin, c-Myc, and Cyclin D1 Expression.
Zhang Y; Tan Y; Wang H; Xu M; Xu L
Med Sci Monit; 2019 Oct; 25():7652-7659. PubMed ID: 31604907
[TBL] [Abstract][Full Text] [Related]
18. Characterization of c-kit (CD117) expression in human normal pituitary cells and pituitary adenomas.
La Rosa S; Uccella S; Dainese L; Marchet S; Placidi C; Vigetti D; Capella C
Endocr Pathol; 2008; 19(2):104-11. PubMed ID: 18568298
[TBL] [Abstract][Full Text] [Related]
19. Essential roles of mesenchyme-derived beta-catenin in mouse Müllerian duct morphogenesis.
Deutscher E; Hung-Chang Yao H
Dev Biol; 2007 Jul; 307(2):227-36. PubMed ID: 17532316
[TBL] [Abstract][Full Text] [Related]
20. β-Catenin knockdown inhibits pituitary adenoma cell proliferation and invasion via interfering with AKT and gelatinases expression.
Zhao C; Zhang M; Liu W; Wang C; Zhang Q; Li W
Int J Oncol; 2015 Apr; 46(4):1643-50. PubMed ID: 25646597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
